Exelixis, Inc.EXEL

Where EXEL's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$56.12-1.31 (-2.28%)Previous close
NASDAQHealthcare

EXEL Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
EXEL Net Debt / EBITDA historyEXEL Net Debt / EBITDA from Sep 2023 to Jul 2026: low -3.11, high 0.02, latest -0.11.-3.36-2.46-1.55-0.640.27Sep 23Mar 24Sep 24Jul 25Jan 26Jul 26med -0.11

EXEL Net Debt / EBITDA by year

Yearly range of EXEL’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from -5.1 to 0.0, averaging -1.2.

EXEL Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
2026-0.3-0.2-0.1-0.1
2025-0.2-0.10.0-0.2
2024-0.3-0.1-0.0-0.0
2023-3.1-1.8-0.4-0.4
2022-1.7-1.4-1.3-1.4
2021-5.1-3.4-2.0-2.0
2020-2.3-1.5-0.9-2.3
2019-0.8-0.7-0.5-0.5
2018-0.9-0.8-0.7-0.7
2017-2.1-1.4-0.9-1.0
2016-1.0-0.9-0.7-1.0

Get notified when EXEL Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.